Precision Medicine

The Annual Meeting of The Menopause Society will have a strong focus on the era of precision medicine in women’s health, especially in the realm of menopause and oncology.

BOSTON — Researchers have identified around 500 genes that directly influence the foods people eat.

SAN DIEGO — In this video exclusive, Richard Pratley, MD, discusses diabetes remission and the need for more information and clinical trials to understand the impact of remission on long-term outcomes.

The recent success of chimeric antigen receptor-T cell therapy, along with three high-profile FDA approvals, may help make precision medicine a reality in lupus, according to a presenter at the Biologic Therapies Summit.

The slow march toward precision medicine in rheumatoid arthritis features increased use of serum biomarkers and novel approaches to biopsy, but “a ton of hurdles” remain, according to a presenter at the Biologic Therapies Summit.

In this episode, host Shikha Jain, MD, speaks with Ken Bloom, MD, FCAP, about developing technologies to assist cancer analysis and pathology, the spatial component of antibody conjugates and more.

DESTIN, Fla. — Efficacy is just one of many factors that should be considered when choosing therapies for rheumatoid arthritis and psoriatic arthritis, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

Emerging precision medicine therapies targeting the molecular causes of cardiomyopathy and HF may improve the outlook for pediatric patients with HF, according to a review published in Translational Pediatrics.

As precision medicine and tumor genomic testing play increasingly important roles in cancer treatment, the challenge of matching patients with appropriate cancer clinical trials has become more daunting.

In this episode, host Shikha Jain, MD, speaks with Edith Perez, MD, about equity initiatives in health care organizations, the evolution of precision oncology and more.